• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase.

作者信息

Vaccaro A M, Muscillo M, Suzuki K

出版信息

Eur J Biochem. 1985 Jan 15;146(2):315-21. doi: 10.1111/j.1432-1033.1985.tb08655.x.

DOI:10.1111/j.1432-1033.1985.tb08655.x
PMID:3967661
Abstract

Properties of glucosylsphingosine (gluco-psychosine) glucosyl hydrolase were studied in detail in cultured human fibroblasts and placenta and were compared with those of glucosylceramidase. The two activities, that are deficient in tissues of Gaucher patients, showed minor but consistent differences. The pH optima were 4.8 for psychosine hydrolysis and 5.3 for glucosylceramide hydrolysis. In the presence of oleic acid, taurocholate activated glucosylceramidase more than 10-fold, while it activated psychosine hydrolysis only by about 30%. Triton X-100 was stimulatory for glucosylceramidase but was strongly inhibitory for psychosine hydrolysis. Phospholipids, that increase many times glucosylceramidase activity, were moderately inhibitory to enzymatic hydrolysis of psychosine. The psychosine hydrolase activity was slightly more heat-stable than the glucosylceramidase activity. The Km values for the two substrates were similar; 1.7 X 10(-5) M for psychosine and 2.7 X 10(-5) M for glucosylceramide. The V for glucosylceramide was, however, 100-times that for psychosine hydrolysis. Psychosine acted as a potent non-competitive inhibitor (Ki = 1.8 X 10(-5) M), while glucosylceramide was a weak inhibitor against psychosine hydrolysis. Within the limit of glucosylceramide solubility, psychosine hydrolysis could not be inhibited by more than 50%. Furthermore, the Dixon plot of glucosylceramide inhibition showed an anomalous slope. The ratio of the two activities was similar in fibroblasts, in the placenta mitochondria-lysosomal fraction and in a partially purified placental preparation. These findings are best explained by the hypothesis that, although the two substrates are hydrolyzed by a single enzyme, they share an overlapping but not identical catalytic site while binding to hydrophobic sites unique for the respective substrates.

摘要

相似文献

1
Characterization of human glucosylsphingosine glucosyl hydrolase and comparison with glucosylceramidase.
Eur J Biochem. 1985 Jan 15;146(2):315-21. doi: 10.1111/j.1432-1033.1985.tb08655.x.
2
Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.人胎盘中一种热稳定因子对葡糖神经酰胺酶、葡糖神经鞘氨醇葡糖水解酶和酸性β-葡糖苷酶活性的影响。
Clin Biochem. 1987 Dec;20(6):429-33. doi: 10.1016/0009-9120(87)90010-5.
3
Specificity of human glucosylceramide beta-glucosidase towards synthetic glucosylsphingolipids inserted into liposomes. Kinetic studies in a detergent-free assay system.人葡糖神经酰胺β-葡萄糖苷酶对插入脂质体的合成葡糖鞘脂的特异性。无去污剂分析系统中的动力学研究。
Eur J Biochem. 1986 Nov 3;160(3):527-35. doi: 10.1111/j.1432-1033.1986.tb10071.x.
4
An endogenous activator protein in human placenta for enzymatic degradation of glucosylceramide.人胎盘中一种用于酶促降解葡萄糖神经酰胺的内源性激活蛋白。
Biochim Biophys Acta. 1985 Sep 11;836(2):157-66. doi: 10.1016/0005-2760(85)90062-1.
5
Presence of activator proteins for the enzymatic degradation of glucosylceramide in several human tissues.
Clin Chim Acta. 1988 Mar 15;172(2-3):323-34. doi: 10.1016/0009-8981(88)90338-5.
6
Factors affecting the binding of glucosylceramidase to its natural substrate dispersion.影响葡萄糖脑苷脂酶与其天然底物分散体结合的因素。
Enzyme. 1989;42(2):87-97. doi: 10.1159/000469014.
7
Purification of glucosylceramidase by affinity chromatography.通过亲和色谱法纯化葡糖神经酰胺酶。
Can J Biochem. 1982 Nov;60(11):1025-31. doi: 10.1139/o82-132.
8
Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.人溶酶体β-葡萄糖苷酶:催化、苷元及疏水结合位点的动力学特征
Arch Biochem Biophys. 1984 May 15;231(1):144-57. doi: 10.1016/0003-9861(84)90371-0.
9
Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease.使用N-(1-[¹⁴C]己酰基)-D-赤型葡糖基神经鞘氨醇分析葡萄糖脑苷脂酶活性,结果显示残余酶活性水平与戈谢病类型之间存在相关性。
Biochem J. 1994 Oct 15;303 ( Pt 2)(Pt 2):377-82. doi: 10.1042/bj3030377.
10
Correlation between the activity of glucosylceramidase and its binding to glucosylceramide-containing liposomes. Role of acidic phospholipids and fatty acids.葡萄糖神经酰胺酶活性与其与含葡萄糖神经酰胺脂质体结合之间的相关性。酸性磷脂和脂肪酸的作用。
Biochim Biophys Acta. 1990 Jan 29;1033(1):73-9. doi: 10.1016/0304-4165(90)90196-4.

引用本文的文献

1
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct.针对β-葡糖脑苷脂酶缺乏引起的神经元溶酶体功能障碍,采用基于酶的脑穿梭构建体。
Nat Commun. 2023 Apr 12;14(1):2057. doi: 10.1038/s41467-023-37632-4.
2
LRRK2 and Lipid Pathways: Implications for Parkinson's Disease.LRRK2 与脂质代谢通路:帕金森病的相关影响。
Biomolecules. 2022 Oct 30;12(11):1597. doi: 10.3390/biom12111597.
3
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.
维格司他联合伊米苷酶治疗戈谢病 3 型成人神经病变:LEAP 试验。
Brain. 2023 Feb 13;146(2):461-474. doi: 10.1093/brain/awac379.
4
Gaucher disease: Basic and translational science needs for more complete therapy and management.戈谢病:实现更全面治疗与管理所需的基础与转化科学
Mol Genet Metab. 2021 Feb;132(2):59-75. doi: 10.1016/j.ymgme.2020.12.291. Epub 2020 Dec 29.
5
Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease.静脉输注 iPSC 源性神经前体细胞可增加脑内酸性 β-葡萄糖苷酶的功能,并减轻戈谢病小鼠模型中的神经病变表型。
Hum Mol Genet. 2019 Oct 15;28(20):3406-3421. doi: 10.1093/hmg/ddz184.
6
Glucosylsphingosine Causes Hematological and Visceral Changes in Mice-Evidence for a Pathophysiological Role in Gaucher Disease.葡萄糖脑苷脂引起小鼠血液学和内脏变化-戈谢病发病机制中的作用证据。
Int J Mol Sci. 2017 Oct 20;18(10):2192. doi: 10.3390/ijms18102192.
7
In situ visualization of glucocerebrosidase in human skin tissue: zymography versus activity-based probe labeling.原位可视化人皮肤组织中的葡萄糖脑苷脂酶:酶谱法与基于活性探针标记法的比较。
J Lipid Res. 2017 Dec;58(12):2299-2309. doi: 10.1194/jlr.M079376. Epub 2017 Oct 12.
8
Lowered humidity produces human epidermal equivalents with enhanced barrier properties.湿度降低会产生具有增强屏障特性的人表皮替代物。
Tissue Eng Part C Methods. 2015 Jan;21(1):15-22. doi: 10.1089/ten.TEC.2014.0065.
9
Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease.Isofagomine 对戈谢病酸性 β-葡萄糖苷酶变异体和底物水平的体外和体内影响。
J Biol Chem. 2012 Feb 3;287(6):4275-87. doi: 10.1074/jbc.M111.280016. Epub 2011 Dec 13.
10
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response.戈谢氏病患者血浆葡萄糖基神经酰胺升高与其表型、贮积细胞标志物和治疗反应的关系。
Blood. 2011 Oct 20;118(16):e118-27. doi: 10.1182/blood-2011-05-352971. Epub 2011 Aug 25.